Abstract |
This study aims to investigate the protection of dexmedetomidine (Dex) against pulmonary ischemia-reperfusion injury (PIRI) in the mouse model and reveal the mechanism in hypoxia reoxygenation (H/R)-induced mouse pulmonary vascular endothelial cells (MPVECs). The lung wet-to-dry weight ratio, histopathological features, and malondialdehyde (MDA) concentrations were measured. The H/R-induced MPVECs were exposed to Dex, and the cell viability, cell apoptosis and protein expressions were assessed by the Cell Counting Kit-8 (CCK8) assay, flow cytometry and western blot, respectively. In addition, the regulatory relationship between miR-21-5p and orphan nuclear receptor 4A1 (Nr4a1) was revealed by several assays, including the dual- luciferase reporter assay, real-time quantitative polymerase chain reaction (RT-qPCR) and western blot. We found that the Dex treatment significantly alleviated pulmonary injury and decreased the level of MDA and wet/dry weight ratio in PIRI mice. Dex treatment also increased cell viability, reduced apoptotic ratio and downregulated expression levels of Cleaved Caspase-3 and Cleaved Caspase-9 in H/R induced MPVECs. Furthermore, the expression of miR-21-5p was upregulated, while Nr4a1 was downregulated by Dex in a concentration-dependent manner in H/R induced MPVECs. Moreover, Nr4a1 was verified as a target of miR-497-5p. Overexpression of Nr4a1 could reverse the protective effects of Dex on alleviating H/R-induced injury in MPVECs. Taken together, Dex treatment attenuated ischemia-reperfusion induced pulmonary injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
|
Authors | Wei Dong, Hongxia Yang, Minghua Cheng, Xin Zhang, Jingjing Yin, Zhaodong Zeng, Guang Huang |
Journal | Acta biochimica Polonica
(Acta Biochim Pol)
Vol. 67
Issue 4
Pg. 521-529
(Dec 17 2020)
ISSN: 1734-154X [Electronic] Poland |
PMID | 33332077
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic alpha-2 Receptor Agonists
- MIRN-21 microRNA, mouse
- MicroRNAs
- Nr4a1 protein, mouse
- Nuclear Receptor Subfamily 4, Group A, Member 1
- Malondialdehyde
- Dexmedetomidine
- Casp3 protein, mouse
- Casp9 protein, mouse
- Caspase 3
- Caspase 9
|
Topics |
- Adrenergic alpha-2 Receptor Agonists
(pharmacology)
- Animals
- Apoptosis
(drug effects)
- Base Pairing
- Base Sequence
- Caspase 3
(genetics, metabolism)
- Caspase 9
(genetics, metabolism)
- Cell Survival
(drug effects)
- Dexmedetomidine
(pharmacology)
- Endothelial Cells
(drug effects, metabolism, pathology)
- Female
- Gene Expression Regulation
- HEK293 Cells
- Humans
- Lung
(drug effects, metabolism, pathology)
- Malondialdehyde
(antagonists & inhibitors, metabolism)
- Mice
- Mice, Inbred C57BL
- MicroRNAs
(genetics, metabolism)
- Nuclear Receptor Subfamily 4, Group A, Member 1
(antagonists & inhibitors, genetics, metabolism)
- Reperfusion Injury
(drug therapy, genetics, metabolism, pathology)
- Signal Transduction
|